Phase I trial of single and multiple doses of non-toxigenic Clostridium difficile (NTCD) in volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2010
At a glance
- Drugs VP 20621 (Primary)
- Indications Clostridium infections
- Focus Adverse reactions
- Sponsors ViroPharma
- 16 Sep 2010 New trial record
- 15 Sep 2010 Data were presented at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (poster session F1-2127b), according to a ViroPharma media release.